688108.SS SHH
Sino Medical Sciences Technology Inc.
1W: -7.5%
1M: -11.0%
3M: -22.6%
YTD: -33.8%
1Y: -27.2%
3Y: +47.2%
5Y: +21.9%
¥14.87 ($2.22)
+0.22 (+1.50%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Cash Flow Trends
Operating Cash Flow
$162M
+23.3% ▲
5Y CAGR: +18.1%
Capital Expenditures
$46M
+34.6% ▲
5Y CAGR: -16.5%
Free Cash Flow
$116M
+89.6% ▲
Dividends Paid
$0
+100.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$292M
-383.1% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$131M | -$173M | -$43M | -$4M | $47M |
| Depreciation & Amort. | $65M | $63M | $63M | $78M | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 | $0 |
| Change in Working Capital | -$22M | -$51M | $12M | $17M | -$12M |
| Other Non-Cash Items | $27M | $49M | $25M | $40M | $127M |
| Operating Cash Flow | -$60M | -$111M | $57M | $131M | $162M |
| — Investing Activities — | |||||
| Capital Expenditures | -$158M | -$111M | -$68M | -$70M | -$46M |
| Acquisitions (Net) | -$26M | $21K | -$126M | -$20M | $2M |
| Investment Purchases | -$306M | -$150M | -$57M | -$17M | $0 |
| Investment Sales | $303M | $172M | $57M | $17M | $0 |
| Other Investing | $663K | $2 | $0 | $833K | $0 |
| Investing Cash Flow | -$187M | -$89M | -$193M | -$89M | -$44M |
| — Financing Activities — | |||||
| Net Debt Issuance | $5M | $30M | $69M | $8M | -$6M |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | -$29K | -$940K | -$2M | -$4M | $0 |
| Other Financing | -$14M | $87M | $55M | $58M | -$6M |
| Financing Cash Flow | -$9M | $117M | $122M | $61M | -$12M |
| Net Change in Cash | -$257M | -$84M | -$15M | $103M | -$292M |
| Cash End of Period | $288M | $203M | $189M | $292M | $0 |
| Free Cash Flow | -$219M | -$222M | -$11M | $61M | $116M |